Nearwater Capital Markets, Ltd
Source: SEC Form 13F · as of Mar 2026Nearwater Capital Markets, Ltd holds 11 biotech & pharma companies tracked by BioSniper, totaling $488.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$488.4M
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 2,150,400 | $113.4M |
| JNJJOHNSON & JOHNSON | 370,000 | $90.4M |
| RVMDREVOLUTION MEDICINES, INC. | 678,000 | $65.9M |
| INSMINSMED Inc | 300,000 | $49.1M |
| ABTABBOTT LABORATORIES | 425,000 | $43.6M |
| LLYELI LILLY & Co | 40,000 | $36.8M |
| GILDGILEAD SCIENCES, INC. | 200,000 | $27.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 90,000 | $24.4M |
| NKTRNEKTAR THERAPEUTICS | 261,500 | $18.8M |
| ARQTArcutis Biotherapeutics, Inc. | 607,300 | $14.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 5,000 | $3.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.